Strikingly, in stratified analyses based on the molecular type of BC, LAG-3<sup>+</sup> lymphocyte infiltration was remarkably associated with better OS rather than DFS in triple-negative breast cancer (TNBC), whereas it significantly influenced neither OS nor DFS in Her2-positive BC. Here, ERBB2 is linked to breast cancer.